Harmony Biosciences to present EPX-100 encore data at European Epilepsy Congress
Harmony Biosciences Holdings plans to present encore data from its EPX-100 (clemizole hydrochloride) investigation at the 16th European Epilepsy Congress, Sept. 5-9 in At…
PLYMOUTH MEETING, Pa., Sept.
03, 2026 (GLOBE NEWSWIRE) -- Harmony Biosciences Holdings, Inc.
NASDAQ:HRMY today announced that it will present encore data from the company’s investigation of EPX-100 (clemizole hydrochloride) at the 16th European Epilepsy Congress being held from September 5-9, in At…